Latest updates for Her+

Fresh curated links around HER+ are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Estrogen Receptor (ER) Positive Breast Cancer
  • 5 Alarming Real-World Findings in HR-Positive, HER2-Low Metastatic Breast Cancer
  • <![CDATA[FDA Approves Revtorpyk for Treatment of Advanced HR-Positive, HER2-Negative Breast Cancer ]]>

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

letlifehappen.com /1 month ago

Estrogen Receptor (ER) Positive Breast Cancer

From: healthline.com Key Takeaways ER-positive breast cancer means cancer cells have estrogen receptors that promote tumor growth when bound to estrogen. It is the most common type...

Read source
letlifehappen.com /1 day ago

5 Alarming Real-World Findings in HR-Positive, HER2-Low Metastatic Breast Cancer

From: oncodaily.com For patients with hormone receptor–positive metastatic breast cancer, the therapeutic landscape has expanded dramatically. CDK4/6 inhibitors transformed first-l...

Read source
pharmexec.com /1 month ago

&lt;![CDATA[FDA Approves Revtorpyk for Treatment of Advanced HR-Positive, HER2-Negative Breast Cancer ]]&gt;

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Her+

feeds.feedburner.com

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source